The mechanisms that regulate a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR), synthesis, transport, targeting and surface expression are of fundamental importance to understand the molecular basis of fast excitatory neurotransmission and synaptic plasticity in the mammalian CNS. An area of intense current interest is how AMPARs are directed to the correct locations in the neuron as and when required. This is a multi-layered problem, which involves complex spatiotemporal coordination of multiple protein interactions. Considerable progress has been achieved in identifying a number of proteins that bind directly to AMPAR subunits and the functional consequences of blocking some of these interactions have been determined. This review highlights recent developments in the field. #
General trafficking processes
General protein transport requires bidirectional vesicle trafficking between cell compartments that are dependent on a range of trafficking molecules (for reviews, see Teasdale and Jackson, 1996; Klumperman, 2000; Mostov et al., 2000) . The final destination of proteins is determined by intrinsic targeting motifs encoded in their amino acid sequences and/or by binding other proteins that contain such motifs.
Most vesicle trafficking requires the ordered coating of a donor membrane, budding, fission to form transport vesicles, transport by passive or active vectoral delivery along microtubules (Antonny and Schekman, 2001 ) and final fusion with the target membrane. The fidelity of these processes is maintained by specific vand t-SNAREs (Pfeffer, 1996) and by spatial and temporal regulation by vesicle and target membrane lipid interactions via Rab-GTPases, tethering proteins and phosphoinositides (Sato et al., 2001) .
As a rule, only fully processed and correctly folded nascent proteins are exported from the ER to the Golgi.
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